Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-15.21	332.83	392.51
Graham Fair Price	31.26	0.08	0.06
PEG	-78.35	1.30	-6.01
Price/Book	-7.28	15.82	17.07
Price/Cash Flow	42.36	343.43	241.25
Prices/Earnings	-42.12	182.29	314.97
Price/Sales	8.49	73.54	67.78
Price/FCF	42.36	343.43	241.25
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.23	0.29	0.26
Operating Margin	587.13	0.15	0.02
ROA	68.45	< 0.005	< 0.005
ROE	0.01	0.02	60.21
ROIC	< 0.005	0.01	253.11
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	-0.28	-86.03
Dividends QOQ	< 0.005	-0.15	-1875.74
EBIT QOQ	-0.77	5.00	546.83
EPS QOQ	-0.52	1.40	167.27
FCF QOQ	1.41	-0.33	-76.32
Revenue QOQ	-0.18	-0.13	28.42
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	38.55	46.71	21.18
Days Sales Outstanding (DSO)	370.17	402.29	8.68
Inventory Turnover	2.33	1.93	-17.48
Debt/Capitalization	0.49	0.49	0.87
Quick Ratio	0.47	0.46	-3.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.11	0.11	3.70
Cash	0.03	0.02	-17.51
Capex	< 0.005	< 0.005	27.59
Free Cash Flow	< 0.005	< 0.005	-32.46
Revenue	0.03	0.02	-11.37
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.54	0.53	-2.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.01	15.07	0.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating